Skip to Content


Chloropicrin From China

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


On the basis of the record [1] developed in the subject five-year review, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)) (the Act), that revocation of the antidumping duty order on chloropicrin from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.


The Commission instituted this review on March 1, 2004 (69 FR 9638) and determined on June 4, 2004 that it would conduct an expedited review (69 FR 34402, June 21, 2004).

The Commission transmitted its determination in this review to the Secretary of Commerce on August 3, 2004. The views of the Commission are contained in USITC Publication 3712 (August 2004), entitled Chloropicrin From China: Investigation No. 731-TA-130 (Second Review).

Start Signature

By order of the Commission.

Issued: August 5, 2004.

Marilyn R. Abbott,

Secretary to the Commission.

End Signature End Preamble


1.  The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)).

Back to Citation

[FR Doc. 04-18249 Filed 8-9-04; 8:45 am]